NNMT and liver cancer: In this pathological state, the disruption of the methyl donor balance, along with the dysregulation of NNMT, SAM, SAH, MNAM, and NAM, may lead to abnormalities in the regulation of NNMT’s metabolic pathways, potentially linking these changes to the pathogenesis of liver cancer.